Clinical Trial Update: Safety Study of Tivanisiran to Treat Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 safety study of tivanisiran for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• tivanisiran

Snippet

Sponsor: Sylentis, S.A. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED